Imaging of mild cognitive impairment and early dementia

N Schuff1, X P Zhu

  • 1University of California, Center for Imaging of Neurodegenerative Diseases Veterans Affairs Medical Center, San Francisco, California, USA. norbert.schuff@ucsf.edu

Insights

Mild cognitive impairment (MCI) bridges normal aging and dementia, potentially indicating early Alzheimer's disease (AD). Brain imaging techniques like MRI and PET offer insights into MCI progression and therapeutic possibilities.

Area of Science:

  • Neurology
  • Radiology
  • Gerontology

Background:

  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.
  • MCI is of significant interest as a potential prodromal phase of Alzheimer's disease (AD).
  • Not all individuals with MCI progress to AD, highlighting the need for accurate diagnostic and prognostic tools.

Purpose of the Study:

  • To review key findings from brain imaging studies in MCI.
  • To discuss the utility of various imaging modalities for MCI diagnosis, outcome prediction, and therapeutic assessment.
  • To explore the potential of imaging as a window for effective therapeutic interventions in MCI.

Main Methods:

  • Review of structural brain changes using Magnetic Resonance Imaging (MRI).
  • Assessment of white matter integrity using Diffusion Tensor Imaging (DTI).
  • Evaluation of altered brain activity and blood flow using Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT), and Arterial Spin Labelling MRI (ASL-MRI).

Main Results:

  • Structural MRI reveals brain changes associated with MCI.
  • DTI demonstrates white matter alterations in individuals with MCI.
  • PET, SPECT, and ASL-MRI show altered brain activity and perfusion in MCI, offering insights into disease mechanisms.

Conclusions:

  • Brain imaging provides valuable insights into the pathophysiology of MCI.
  • Different imaging modalities have unique strengths and limitations for MCI diagnosis and prognosis.
  • Imaging plays a crucial role in identifying therapeutic targets and assessing treatment efficacy in MCI.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET